Real-World Clinical Outcomes of Teclistamab and Talquetamab in Relapsed/Refractory Multiple Myeloma (RRMM): A UK Single-Centre Experience

被引：0

作者：

Feixas, Pablo Tenorio ^{[1
]}

Cox, Catrin ^{[1
]}

Peer, Xavier ^{[1
]}

Cuthill, Kirsty ^{[1
]}

Benjamin, Reuben ^{[2
]}

Gunawan, Arief ^{[2
]}

Cuadrado, Maria ^{[1
]}

de Farias, Madson Correia ^{[1
]}

Jones, John ^{[1
]}

Shin, Jin-Sup ^{[1
]}

Batool, Asma ^{[1
]}

Bowcock, Stella ^{[1
]}

Omer, Musab ^{[1
]}

Tawde, Prachi ^{[1
]}

Bailey, Katharine ^{[1
]}

机构：

[1] Kings Coll Hosp NHS Fdn Trust, London, England

[2] Kings Coll Hosp London, London, England

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-087

引用

页码：S92 / S92

页数：1

共 50 条

[1] Real-World Evaluation of Teclistamab for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM)
Asoori, Sireesha
Popat, Rakesh
Martinez-Lopez, Joaquin
Kastritis, Efstathios
Brunaldi, Larissa
Bansal, Radhika
Corraes, Andre De Menezes Silva
Yong, Kwee
Mactier, Catriona
Corona, Magdalena
Saez Marin, Adolfo Jesus
Fotiou, Despina
Dimopoulos, Meletios Athanasios
Chhabra, Saurabh
Ailawadhi, Sikander
Parrondo, Ricardo
Martin, Thomas
Durie, Brian G. M.
Lin, Yi
BLOOD, 2023, 142
[2] Real-World Experience With Talquetamab Clinical Management in Relapsed Refractory Multiple Myeloma (RRMM): A Qualitative Study of US Healthcare Providers
Schinke, Carolina
Dhakal, Binod
Mazzoni, Sandra
Shenoy, Samantha
Scott, Sara
Richards, Tiffany
Le, Hoa
DeBrosse, Amalia
Okorozo, Peter
McDowell, Rachel
Patel, Saurabh
Bunn, Jonathan
Hawks, Kelly
Zhang, Xinke
Rodriguez-Valdes, Cesar
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S265 - S266
[3] Real World Evaluation of Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma (RRMM)
Maringanti, Sireesha Asoori
Lin, Yi
Estritis, Stathis
Martinez-Lopez, Joaquin
Bansal, Radhika
Fotiou, Despina
Corona, Magdalena
Chhabra, Saurabh
Brunaldi, Larissa
Corraes, Andre De Menezes Silva
Parrondo, Ricardo
Kapoor, Prashant
Ailawadhi, Sikander
Mas, Reyes
Tamayo, Andrea
Dimopoulos, Meletios
Durie, Brian
Martin, Thomas
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S506 - S507
[4] Teclistamab in Relapsed/Refractory Multiple Myeloma: Real-World Outcomes at a Single Academic Center in the Midwest
Stepanovic, Adam
Abonour, Rafat
Abu Zaid, Mohammad
Farag, Sherif
Lee, Kelvin P.
Suvannasankha, Attaya
BLOOD, 2023, 142
[5] Real-World Outcomes of Patients with Relapsed/Refractory Multiple Myeloma Treated with Teclistamab and Talquetamab; A Multicenter Analysis from the Greek Myeloma Study Group
Ntanasis-Stathopoulos, Ioannis
Katodrytou, Eirini
Hatjiharissi, Evdoxia
Spanoudakis, Emmanouil
Douka, Vasiliki
Fotiou, Despina
Labropoulou, Vasiliki
Dalampira, Dimitra
Spiliopoulou, Vasiliki
Papadopoulou, Theodosia
Christoulas, Dimitrios
Malandrakis, Panagiotis
Bouchla, Anthi
Pappa, Vasiliki
Kastritis, Efstathios
Terpos, Evangelos
Dimopoulos, Meletios
Gavriatopoulou, Maria
BLOOD, 2024, 144 : 6988 - 6990
[6] Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
Cohen, Yael C.
Magen, Hila
Gatt, Moshe
Sebag, Michael
Kim, Kihyun
Min, Chang-Ki
Ocio, Enrique M.
Yoon, Sung-Soo
Chu, Michael P.
Rodriguez-Otero, Paula
Avivi, Irit
Quijano Carde, Natalia A.
Kumar, Ashwini
Krevvata, Maria
Peterson, Michelle R.
Di Scala, Lilla
Scott, Emma
Hilder, Brandi
Vanak, Jill
Banerjee, Arnob
Oriol, Albert
Morillo, Daniel
Mateos, Maria-Victoria
NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (02): : 138 - 149
[7] Teclistamab for Relapsed/Refractory Multiple Myeloma: Real-World Experience in an Early Access Program
Uttervall, Katarina
Nahi, Hareth
Kashif, Muhammad
Lemonakis, Konstantinos
Rosengren, Sara
Brolin, Janaki
Lund, Johan
Hansson, Markus
BLOOD, 2022, 140 : 12605 - 12606
[8] Safety and Efficacy of Teclistamab in Patients with Relapsed/ Refractory Multiple Myeloma: A Real-World Experience
Dima, Danai
Davis, James A.
Ahmed, Nausheen
Jia, Xuefei
Sannareddy, Aishwarya
Shaikh, Hira
Shune, Leyla
Kaur, Gurbakhash
Khouri, Jack
Afrough, Aimaz
Strouse, Christopher
Lochner, Jonathan
Mahmoudjafari, Zahra
Raza, Shahzad
Valent, Jason
Anderson Jr, Larry D.
Anwer, Faiz
Abdallah, Al-Ola
Hashmi, Hamza
TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (03): : 308.e1 - 308.e13
[9] Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): an International Myeloma Working Group Study
Tan, Carlyn Rose
Asoori, Sireesha
Huang, Chiung-Yu
Brunaldi, Larissa
Popat, Rakesh
Kastritis, Efstathios
Martinez-Lopez, Joaquin
Bansal, Radhika
Corraes, Andre De Menezes Silva
Chhabra, Saurabh
Parrondo, Ricardo
Ailawadhi, Sikander
Fotiou, Despina
Dimopoulos, Meletios A.
Yong, Kwee
Mactier, Catriona
Lau, Chris
Corona, Magdalena
Marin, Adolfo Jesus Saez
Mian, Hira
Durie, Brian GM.
Usmani, Saad Z.
Martin, Thomas G.
Lin, Yi
BLOOD CANCER JOURNAL, 2025, 15 (01):
[10] Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium
Razzo, Beatrice
Grajales-Cruz, Ariel
Atrash, Shebli
Ferreri, Christopher
Goyal, Anmol
Pasvolsky, Oren
Banerjee, Rahul
Julian, Kelley
Forsberg, Peter
Herr, Megan
Lin, Yi
Susanibar-Adaniya, Sandra
Khouri, Jack
Vazquez-Martinez, Mariola
Lee, Hans
Portuguese, Andrew
Sborov, Douglas W.
Dima, Danai
Davis, James
Kaur, Gurbakhash
Shune, Leyla
Hansen, Doris
Sidana, Surbhi
Garfall, Alfred
Richard, Shambavi
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S82 - S83

← 1 2 3 4 5 →